How to Develop a Global Clinical Trial Budget Like a Pro

Victor is an industry expert on budget development and negotiation for Investigative Sites, and is part of the Business Analytics team for heritage Celgene. After originally working in the labs, he has worked in the pharmaceutical industry for over 15 years. While at Celgene, in 2010 he was responsible for developing and implementing new procedures for site budget development to reflect business and study needs at that time. Victor then created a new site budget appendix format with a separate payment terms document, which have been in use since Jan 2012. As process owner, he has evolved these templates over time to improve negotiation efficiency and to incorporate current industry trends. Victor continues to lead and participate in many initiatives for process improvement within CR&D, coordinating with clinical functions as well as finance and project management. In his role within Business Analytics, his main responsibilities are budget forecasting for clinical trials and development of investigator grants; from providing high-level estimates for a study concept, preparing detailed estimates for governance presentations, and to the creation and approval of global site budget templates based upon a finalized protocol. As part of this function, he also helps clinical teams with protocols and amendments in development to mitigate complexity with trial design. Victor has experience with investigator- and sponsor-initiated budgets for clinical pharmacology through post-marketing studies, primarily in oncology but other therapeutic areas as well. Victor graduated Rutgers University in the pre-medical track with a B.S. focusing on human biology.